Efficient preparation of human and mouse CD1d proteins using silkworm baculovirus expression system.

Baculovirus CD1d Differential scanning calorimetry Major histocompatibility complex class I Secretory expression Silkworm

Journal

Protein expression and purification
ISSN: 1096-0279
Titre abrégé: Protein Expr Purif
Pays: United States
ID NLM: 9101496

Informations de publication

Date de publication:
08 2020
Historique:
received: 15 02 2020
revised: 14 03 2020
accepted: 20 03 2020
pubmed: 28 3 2020
medline: 21 1 2021
entrez: 28 3 2020
Statut: ppublish

Résumé

CD1d is a major histocompatibility complex (MHC) class I-like glycoprotein and binds to glycolipid antigens that are recognized by natural killer T (NKT) cells. To date, our understanding of the structural basis for glycolipid binding and receptor recognition of CD1d is still limited. Here, we established a preparation method for the ectodomain of human and mouse CD1d using a silkworm-baculovirus expression system. The co-expression of human and mouse CD1d and β2-microglobulin (β2m) in the silkworm-baculovirus system was successful, but the yield of human CD1d was low. A construct of human CD1d fused with β2m via a flexible GS linker as a single polypeptide was prepared to improve protein yield. The production of this single-chained complex was higher (50 μg/larva) than that of the co-expression complex. Furthermore, differential scanning calorimetry revealed that the linker made the CD1d complex more stable and homogenous. These results suggest that the silkworm-baculovirus expression system is useful for structural and biophysical studies of CD1d in several aspects including low cost, easy handling, biohazard-free, rapid, and high yielding.

Identifiants

pubmed: 32213313
pii: S1046-5928(19)30642-4
doi: 10.1016/j.pep.2020.105631
pii:
doi:

Substances chimiques

Antigens, CD1d 0
CD1D protein, human 0
CD1d antigen, mouse 0
Recombinant Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

105631

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Hiroki Kusaka (H)

Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, 060-0812, Japan.

Shunsuke Kita (S)

Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, 060-0812, Japan.

Takashi Tadokoro (T)

Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, 060-0812, Japan.

Kouki Yoshida (K)

Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, 060-0812, Japan.

Yoshiyuki Kasai (Y)

Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, 060-0812, Japan.

Harumi Niiyama (H)

Department of Chemistry, Graduate School of Science, Osaka University, 1-1 Machikaneyama, Toyonaka, Osaka, 560-0043, Japan.

Yukari Fujimoto (Y)

Department of Chemistry, Faculty of Science and Technology, Keio University, Yokohama, 223-8522, Japan.

Shinya Hanashima (S)

Department of Chemistry, Graduate School of Science, Osaka University, 1-1 Machikaneyama, Toyonaka, Osaka, 560-0043, Japan.

Michio Murata (M)

Department of Chemistry, Graduate School of Science, Osaka University, 1-1 Machikaneyama, Toyonaka, Osaka, 560-0043, Japan.

Shigeru Sugiyama (S)

Department of Chemistry, Graduate School of Science, Osaka University, 1-1 Machikaneyama, Toyonaka, Osaka, 560-0043, Japan; Faculty of Science & Technology, Kochi University, Kochi, 780-8520, Japan.

Toyoyuki Ose (T)

Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, 060-0812, Japan; Graduate School of Life Science, Hokkaido University, Sapporo, Hokkaido, 060-0810, Japan; Faculty of Advanced Life Science, Hokkaido University, Sapporo, 060-0810, Japan.

Kimiko Kuroki (K)

Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, 060-0812, Japan.

Katsumi Maenaka (K)

Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, 060-0812, Japan; Graduate School of Life Science, Hokkaido University, Sapporo, Hokkaido, 060-0810, Japan. Electronic address: maenaka@pharm.hokudai.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH